Animation-Based Education to Reduce Child and Parent Anxiety During Pediatric Stem Cell Transplan… (NCT07514442) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Animation-Based Education to Reduce Child and Parent Anxiety During Pediatric Stem Cell Transplantation (Cartoon-HSCT)
Turkey (Türkiye)34 participantsStarted 2026-04
Plain-language summary
The goal of this clinical trial is to evaluate the effect of animation-based education on state anxiety levels of children and parents and on parental satisfaction with health care during the pediatric hematopoietic stem cell transplantation (HSCT) process.
The main questions it aims to answer are:
Does animation-based education reduce children's state anxiety before HSCT compared to standard verbal education? Does animation-based education reduce parental state anxiety and increase parental satisfaction with the care process?
Researchers will compare children and parents who receive animation-based education with those who receive routine verbal education to see if the animation-based intervention leads to lower anxiety scores and higher satisfaction levels.
Participants will:
Watch a short age-appropriate animated video explaining the HSCT procedure in a positive and understandable way (intervention group), or receive standard verbal information (control group).
Complete pre- and post-intervention questionnaires assessing child and parent state anxiety levels and parental satisfaction with care.
The study includes children aged 4-10 years who are hospitalized for hematopoietic stem cell transplantation and their accompanying parents.
Who can participate
Age range
4 Years – 10 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
Children:
Aged 4 to 10 years. Scheduled for hematopoietic stem cell transplantation. No previous history of hematopoietic stem cell transplantation. Ability to communicate verbally in Turkish. No diagnosed cognitive impairment. Provided age-appropriate verbal assent if aged 7 years or older. Written informed consent provided by a legal parent or guardian.
Parents:
Parent or legal guardian of a child aged 4 to 10 years scheduled for hematopoietic stem cell transplantation.
Remaining with the child as the primary caregiver/companion throughout the HSCT hospitalization.
Ability to communicate verbally in Turkish. Willingness to participate and provision of written informed consent.
Exclusion Criteria:
Children:
Native language other than Turkish or significant difficulty communicating in Turkish.
Previous hematopoietic stem cell transplantation. Development of severe clinical complications before or during transplantation requires modification of the treatment protocol.
Transfer to another clinic prior to transplantation. Significant emotional distress during the animation intervention, as assessed by the research team.
Parents:
Native language other than Turkish or significant difficulty communicating in Turkish.
Change in caregiver/companion role during the transplantation process.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Change in Child State Anxiety
Timeframe: Baseline (before intervention, prior to HSCT) Immediately after the intervention procedure (same day, after HSCT)